中国年轻糖尿病患者中的单基因糖尿病:香港一项为期 17 年的前瞻性随访研究。

IF 4.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Sandra T. F. Tsoi, Cadmon Lim, Ronald C. W. Ma, Eric S. H. Lau, Baoqi Fan, Elaine Chow, Alice P. S. Kong, Juliana C. N. Chan, Andrea O. Y. Luk
{"title":"中国年轻糖尿病患者中的单基因糖尿病:香港一项为期 17 年的前瞻性随访研究。","authors":"Sandra T. F. Tsoi,&nbsp;Cadmon Lim,&nbsp;Ronald C. W. Ma,&nbsp;Eric S. H. Lau,&nbsp;Baoqi Fan,&nbsp;Elaine Chow,&nbsp;Alice P. S. Kong,&nbsp;Juliana C. N. Chan,&nbsp;Andrea O. Y. Luk","doi":"10.1002/dmrr.3823","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aims</h3>\n \n <p>Asians have a high prevalence of young-onset diabetes, but the pattern of monogenic diabetes is unknown. We aimed to determine the prevalence of monogenic diabetes in Chinese patients with young-onset diabetes and compare the clinical characteristics and outcome between patients with and without monogenic diabetes.</p>\n </section>\n \n <section>\n \n <h3> Materials and Methods</h3>\n \n <p>We sequenced a targeted panel of 33 genes related to monogenic diabetes in 1021 Chinese patients with non-type 1 diabetes diagnosed at age ≤40 years. Incident complications including cardiovascular disease (CVD), end-stage kidney disease (ESKD) and all-cause death were captured since enrolment (1995–2012) until 2019.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In this cohort (mean ± SD age at diagnosis: 33.0 ± 6.0 years, median[IQR] diabetes duration 7.0[1.0–15.0] years at baseline, 44.9% men), 22(2.2%, 95% confidence interval[CI] 1.4%–3.2%) had monogenic diabetes. Pathogenic (P) or likely pathogenic (LP) variants were detected in <i>GCK</i> (<i>n</i> = 6), <i>HNF1A</i> (<i>n</i> = 9), <i>HNF4A</i> (<i>n</i> = 1), <i>PLIN1</i> (<i>n</i> = 1) and <i>PPARG</i> (<i>n</i> = 2), together with copy number variations in <i>HNF1B</i> (<i>n</i> = 3). Over a median follow-up of 17.1 years, 5(22.7%) patients with monogenic diabetes (incidence rate 12.3[95% CI 5.1–29.4] per 1000 person-years) versus 254(25.4%) without monogenic diabetes (incidence rate 16.7[95% CI 14.8–18.9] per 1000 person-years) developed the composite outcome of CVD, ESKD and/or death (<i>p</i> = 0.490). The multivariable Cox model did not show any difference in hazards for composite events between groups.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>In Chinese with young-onset non-type 1 diabetes, at least 2% of cases were contributed by monogenic diabetes, over 80% of which were accounted for by P/LP variants in common MODY genes. The incidence of diabetes complications was similar between patients with and without monogenic diabetes.</p>\n </section>\n </div>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"40 5","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.3823","citationCount":"0","resultStr":"{\"title\":\"Monogenic diabetes in a Chinese population with young-onset diabetes: A 17-year prospective follow-up study in Hong Kong\",\"authors\":\"Sandra T. F. Tsoi,&nbsp;Cadmon Lim,&nbsp;Ronald C. W. Ma,&nbsp;Eric S. H. Lau,&nbsp;Baoqi Fan,&nbsp;Elaine Chow,&nbsp;Alice P. S. Kong,&nbsp;Juliana C. N. Chan,&nbsp;Andrea O. Y. Luk\",\"doi\":\"10.1002/dmrr.3823\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Aims</h3>\\n \\n <p>Asians have a high prevalence of young-onset diabetes, but the pattern of monogenic diabetes is unknown. We aimed to determine the prevalence of monogenic diabetes in Chinese patients with young-onset diabetes and compare the clinical characteristics and outcome between patients with and without monogenic diabetes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Materials and Methods</h3>\\n \\n <p>We sequenced a targeted panel of 33 genes related to monogenic diabetes in 1021 Chinese patients with non-type 1 diabetes diagnosed at age ≤40 years. Incident complications including cardiovascular disease (CVD), end-stage kidney disease (ESKD) and all-cause death were captured since enrolment (1995–2012) until 2019.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>In this cohort (mean ± SD age at diagnosis: 33.0 ± 6.0 years, median[IQR] diabetes duration 7.0[1.0–15.0] years at baseline, 44.9% men), 22(2.2%, 95% confidence interval[CI] 1.4%–3.2%) had monogenic diabetes. Pathogenic (P) or likely pathogenic (LP) variants were detected in <i>GCK</i> (<i>n</i> = 6), <i>HNF1A</i> (<i>n</i> = 9), <i>HNF4A</i> (<i>n</i> = 1), <i>PLIN1</i> (<i>n</i> = 1) and <i>PPARG</i> (<i>n</i> = 2), together with copy number variations in <i>HNF1B</i> (<i>n</i> = 3). Over a median follow-up of 17.1 years, 5(22.7%) patients with monogenic diabetes (incidence rate 12.3[95% CI 5.1–29.4] per 1000 person-years) versus 254(25.4%) without monogenic diabetes (incidence rate 16.7[95% CI 14.8–18.9] per 1000 person-years) developed the composite outcome of CVD, ESKD and/or death (<i>p</i> = 0.490). The multivariable Cox model did not show any difference in hazards for composite events between groups.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>In Chinese with young-onset non-type 1 diabetes, at least 2% of cases were contributed by monogenic diabetes, over 80% of which were accounted for by P/LP variants in common MODY genes. The incidence of diabetes complications was similar between patients with and without monogenic diabetes.</p>\\n </section>\\n </div>\",\"PeriodicalId\":11335,\"journal\":{\"name\":\"Diabetes/Metabolism Research and Reviews\",\"volume\":\"40 5\",\"pages\":\"\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.3823\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes/Metabolism Research and Reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/dmrr.3823\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes/Metabolism Research and Reviews","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/dmrr.3823","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:亚洲人的年轻糖尿病发病率很高,但单基因糖尿病的发病模式尚不清楚。我们旨在确定中国年轻糖尿病患者中单基因糖尿病的发病率,并比较单基因糖尿病患者和非单基因糖尿病患者的临床特征和预后:我们对1021名年龄≤40岁的中国非1型糖尿病患者中与单基因糖尿病相关的33个基因进行了测序。从入组(1995-2012年)到2019年,我们采集了包括心血管疾病(CVD)、终末期肾病(ESKD)和全因死亡在内的并发症:在该队列中(诊断时的平均 ± SD 年龄:33.0 ± 6.0 岁,基线糖尿病病程中位数[IQR]7.0[1.0-15.0]年,44.9% 为男性),22 人(2.2%,95% 置信区间[CI]1.4%-3.2%)患有单基因糖尿病。GCK (n = 6)、HNF1A (n = 9)、HNF4A (n = 1)、PLIN1 (n = 1) 和 PPARG (n = 2) 中检测到致病变体 (P) 或可能致病变体 (LP),HNF1B (n = 3) 中也有拷贝数变异。在中位 17.1 年的随访期间,5 名(22.7%)单基因糖尿病患者(发病率为每千人年 12.3 例[95% CI 5.1-29.4 例])与 254 名(25.4%)非单基因糖尿病患者(发病率为每千人年 16.7 例[95% CI 14.8-18.9 例])出现了心血管疾病、ESKD 和/或死亡的综合结果(P = 0.490)。多变量考克斯模型显示,各组间发生复合事件的危险度没有差异:结论:在中国年轻的非1型糖尿病患者中,至少有2%的病例是由单基因糖尿病引起的,其中80%以上是由常见的MODY基因中的P/LP变异引起的。单基因糖尿病患者和非单基因糖尿病患者的糖尿病并发症发病率相似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Monogenic diabetes in a Chinese population with young-onset diabetes: A 17-year prospective follow-up study in Hong Kong

Monogenic diabetes in a Chinese population with young-onset diabetes: A 17-year prospective follow-up study in Hong Kong

Aims

Asians have a high prevalence of young-onset diabetes, but the pattern of monogenic diabetes is unknown. We aimed to determine the prevalence of monogenic diabetes in Chinese patients with young-onset diabetes and compare the clinical characteristics and outcome between patients with and without monogenic diabetes.

Materials and Methods

We sequenced a targeted panel of 33 genes related to monogenic diabetes in 1021 Chinese patients with non-type 1 diabetes diagnosed at age ≤40 years. Incident complications including cardiovascular disease (CVD), end-stage kidney disease (ESKD) and all-cause death were captured since enrolment (1995–2012) until 2019.

Results

In this cohort (mean ± SD age at diagnosis: 33.0 ± 6.0 years, median[IQR] diabetes duration 7.0[1.0–15.0] years at baseline, 44.9% men), 22(2.2%, 95% confidence interval[CI] 1.4%–3.2%) had monogenic diabetes. Pathogenic (P) or likely pathogenic (LP) variants were detected in GCK (n = 6), HNF1A (n = 9), HNF4A (n = 1), PLIN1 (n = 1) and PPARG (n = 2), together with copy number variations in HNF1B (n = 3). Over a median follow-up of 17.1 years, 5(22.7%) patients with monogenic diabetes (incidence rate 12.3[95% CI 5.1–29.4] per 1000 person-years) versus 254(25.4%) without monogenic diabetes (incidence rate 16.7[95% CI 14.8–18.9] per 1000 person-years) developed the composite outcome of CVD, ESKD and/or death (p = 0.490). The multivariable Cox model did not show any difference in hazards for composite events between groups.

Conclusions

In Chinese with young-onset non-type 1 diabetes, at least 2% of cases were contributed by monogenic diabetes, over 80% of which were accounted for by P/LP variants in common MODY genes. The incidence of diabetes complications was similar between patients with and without monogenic diabetes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes/Metabolism Research and Reviews
Diabetes/Metabolism Research and Reviews 医学-内分泌学与代谢
CiteScore
17.20
自引率
2.50%
发文量
84
审稿时长
4-8 weeks
期刊介绍: Diabetes/Metabolism Research and Reviews is a premier endocrinology and metabolism journal esteemed by clinicians and researchers alike. Encompassing a wide spectrum of topics including diabetes, endocrinology, metabolism, and obesity, the journal eagerly accepts submissions ranging from clinical studies to basic and translational research, as well as reviews exploring historical progress, controversial issues, and prominent opinions in the field. Join us in advancing knowledge and understanding in the realm of diabetes and metabolism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信